Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print A potential molecular target for biotherapy esophageal squamous cell carcinomas

A potential molecular target for biotherapy esophageal squamous cell carcinomas

February 19, 2009

The cadherin superfamily has a correlate relationship with the invasion and metastasis of carcinoma. It has been suggested that, unlike E-cadherin, N-cadherin may promote motility and invasion in carcinoma cells. To explore clinical pathological significance of E-cadherin and N-cadherin expressions in esophageal squamous cell carcinoma (ESCC), a research team led by Prof. Qing-Xia Fan from China detected the expression of E-cadherin and N-cadherin in 62 cases of normal esophageal epithelium, 31 cases of adjacent atypical hyperplasia epithelium and 62 cases of esophageal squamous cell carcinoma.Their study will be published on February 14, 2009 in the World Journal of Gastroenterology.

They found that the positive rates of N-cadherin decreased in the carcinoma, adjacent atypical hyperplastic and normal esophageal tissues (75.8%, 61.3% and 29.0%, P < 0.05), respectively, while those of E-cadherin increased (40.3%, 71.0% and 95.2%, P < 0.05). The increased expression of N-cadherin and decreased expression of E-cadherin were related to invasion, differentiation, and lymph node metastasis (P < 0.05). The expression level of N-cadherin decreased in the N-cadherin knocked down cells, and the invasiveness of those cells decreased significantly as well. The number of cells which crossed the basement membrane filter decreased from 123.40 ± 8.23 to 49.60 ± 6.80 (P < 0.05).




The results indicated that E-cadherin and N-cadherin expression is correlated with the invasion and aggravation of ESCC. The down-regulation of N-cadherin lowers the invasiveness of EC9706 cell line.

Reference: Li K, He W, Lin N, Wang X, Fan QX. N-cadherin knock-down decreases invasiveness of esophageal squamous cell carcinoma in vitro. World J Gastroenterol 2009; 15(6): 697-704 http://www.wjgnet.com/1007-9327/15/697.asp

World Journal of Gastroenterology




More Esophageal Squamous Cell Carcinomas Current Events and Esophageal Squamous Cell Carcinomas News Articles
  Esophageal Cancer: An Overview.: An article from: MedSurg Nursing
by Jo Ann Brooks-Brunn (Author)

This digital document is an article from MedSurg Nursing, published by Jannetti Publications, Inc. on October 1, 2000. The length of the article is 5165 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the author: Esophageal cancer is the second most common solid intrathoracic malignancy behind lung cancer. Treatment of esophageal cancer is dependent upon the stage of presentation and the options include chemotherapy, radiation therapy, surgery, multimodality therapy, or palliative care. Early detection of this disease is the primary method to decrease its high morbidity and...

© 2009 BrightSurf.com